About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

NCT00648999·13 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AbbVie (prior sponsor, Abbott)

Age

17–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

HIV Infected subjects
Subjects failing in current HIV treatment, or
Subjects with a viral load \< 400 copies/mL and not tolerating their current HIV treatment.

You may not be if

Subject is currently participating in another clinical study or has participated in another clinical study within 30 days prior to screening visit
Subject is pregnant

The record

StatusCompleted

PhasePhase 4

Taking part207

StartedNov 2003

UpdatedMar 15, 2013

Conditions

Human Immunodeficiency Virus

Where13

Site Ref # / Investigator 4074
León, Guanajauto, Mexico
Site Ref # / Investigator 4049
Mexico City, Mexico City, Mexico
Site Ref # / Investigator 4050
Mexico City, Mexico City, Mexico